Seqens
Seqens is a French company specializing in the manufacturing of pharmaceutical ingredients and specialty chemicals. It offers tailored solutions and exceptional market responsiveness to its customers across various industries, including healthcare, electronics, cosmetics, food, and household cleaners.
1 past transactions
CELLforCURE
Acquisition in 2025
CELLforCURE is an innovative company specializing in cell therapy, aimed at supplying hospitals and clinics with advanced therapy medicinal products. It focuses on developing and providing cell and gene therapies, contributing to the evolving landscape of medical treatment. Its operations position it as a significant player in the field, prioritizing the needs of healthcare providers and enhancing patient care through advanced therapeutic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.